Form 8.3

Summary by AI BETAClose X

Qube Research & Technologies Limited disclosed an opening position in Bodycote plc 17 3/11p ordinary shares showing 0 direct holdings and 5,576,589 cash-settled derivatives representing 3.27% of the class as at 02-11-2026, with 0 short positions; recent equity-swap dealings net reduced the long derivative exposure by 9,435 units with trade prices between 915.50p and 917.00p, no stock-settled derivatives or subscription rights were reported, and no indemnities or related arrangements were disclosed (disclosure dated 03-11-2026).

Disclaimer*

Companies

Bodycote (BOY)
UK 100

Latest directors dealings